EXO THERAPEUTICS
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.
EXO THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.exo-therapeutics.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
103 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Global Site Tag
Similar Organizations
Nokang NKD (Nuokang Biotech)
Nokang NKD is the world's leading new drug research and development company
Matrixx Initiatives
Matrixx initiatives is a company focused on the development of OTC medicine.
MHB Labs
MHB Labs is a leader in men's health research and development
Meijer
Meijer is a shopping website for grocery, health, and beauty care.
MitraSpan
MitraSpan is a privately held medical device development company.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Lancet JSC
Lancet JSC is a modern rapidly developing company,
Lifeplan Products
A Leicestershire, UK-based manufacturer of vitamins, minerals and supplements.
leon nanodrugs
leon-nanodrugs is a nanotechnology-based drug development company.
Antisense Therapeutics
Antisense Therapeutics is a biopharmaceutical drug discovery and development company.
Arisan Therapeutics
Arisan Therapeutics is a life science company that develops novel solutions for the treatment of neglected and emerging infectious diseases.
Acrux
Acrux is a dynamic Australian drug delivery business developing Company
Accord Healthcare
Accord Healthcare is an emerging large-scale provider of generic pharmaceuticals.
Altus Formulation
Altus Formulation is a drug formulation and development company
AFT Pharmaceuticals
AFT is a Pharmaceutical sales and development company.
Acellera
Acellera is a company devoted to speed up drug discovery and development.
Arrayjet
Arrayjet is a microarray instrumentation company
Ability Pharmaceuticals
Ability Pharmaceuticals is a drug discovery and development company.
Enzolytics
Enzolytics is a drug development company
Esco Lifesciences
Esco Lifesciences provides enabling technologies, products, and services.
Ogeda
Ogeda is a privately owned clinical-stage drug discovery company.
Bohai New Enzyme
Bohai New Enzyme is a special enzyme research and development manufacturer.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
BioSeek
BioSeek provides cell-based human disease models for drug discovery and development.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Topmunnity Therapeutics
Topmunnity Therapeutics is an oncology focused drug development company.
JINRUI FOUNDATION
JINRUI FOUNDATION is a drug research and development company.
4E Therapeutics
4E Therapeutics is dedicated to developing treatments for neuropathic pain.
Kalyra Pharmaceuticals
Kalyra Pharmaceuticals is a small molecule drug discovery and development company focused on creating best-in-class medicines.
Surface Therapeutics Ltd.
Surface Therapeutics Ltd. is a privately owned drug discovery and development company.
Shiyin Technology
Shiyin Technology is an independent research and development company
Shouyao Holding
Shouyao Holding is a tumor and diabetes drug research and development company.
Shenogen Pharma Group
Shenogen Pharma Group is a drug discovery and development company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Astrotech
Astrotech operates as a science and technology development and commercialization company.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Sterling Pharma Solutions
Sterling Pharma Solutions is a provider of small molecule API development and manufacturing services to the global pharmaceutical industry.
DelSiTech
A Turku, Finland-based drug delivery and drug development company,
Domainex
A fully integrated drug discovery service company.
Dalriada Therapeutics
Dalriada is a small molecule drug discovery company
D Pharm LTD.
D-Pharm is a drug-development company.
Delix Therapeutics
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Helsinn Birex Pharmaceuticals
Helsinn is a world class cancer care company.
Hebei Daan Pharmaceutical Co., Ltd
Hebei Daan Pharmaceutical Co., Ltd is a blood product manufacturing company.
Heidelberg Pharma AG
Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.
IMVAQ Therapeutics
Imvaq Therapeutics is an innovative cancer immunotherapy company.
ImmuPharma
ImmuPharma plc is a United Kingdom-based drug discovery and development company. The Company is focused on developing drugs.
ioTech International
IoTech International focuses on molecular iodine research and development.
Inorbit Therapeutics
Inorbit Therapeutics is a privately owned virtual drug discovery & development company.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Incozen Therapeutics
Incozen Therapeutics is a drug discovery and development company.
Isomerase Therapeutics
Isomerase Therapeutics is an agile drug discovery and development company.
GIANTECH HI-TECHNOLOGY
GIANTECH HI-TECHNOLOGY is a drug development company.
Ora
Ora is an ophthalmic clinical research and product development firm.
X-37
X-37 is a pharmaceutical discovery and development company
Cambrex
Cambrex is a small molecule company that offers drug substance, drug product, and analytical services.
Crystal Pharmatech
Crystal Pharmatech is a solid-state drug development firm.
CG Pharmaceuticals
CG Pharmaceuticals is a structural chemoproteomics-based drug discovery and development company in Seoul, Korea.
ConverGene
ConverGene is a small molecule discovery company leveraging rational drug design.
Claris Lifesciences
Claris Lifesciences is a multi-business enterprise and the holding company.
Performance Health
Performance Health is a global consumer branded health, wellness and self-care company.
Pulse Therapeutics
Pulse Therapeutics is focused on developing vascular drug delivery devices for blood clots in stroke patients.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Casdin Capital
Casdin Capital investment in Series B - Exo Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - Exo Therapeutics
CRV
CRV investment in Series B - Exo Therapeutics
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Exo Therapeutics
6 Dimensions Capital
6 Dimensions Capital investment in Series B - Exo Therapeutics
BVF Partners
BVF Partners investment in Series B - Exo Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Exo Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Exo Therapeutics
Newpath Management
Newpath Management investment in Series B - Exo Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Exo Therapeutics
Key Employee Changes
Official Site Inspections
http://www.exo-therapeutics.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.48 K
- Host name: 104.21.68.238
- IP address: 104.21.68.238
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Exo Therapeutics"
Exo Therapeutics - Crunchbase Company Profile
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep …See details»
Team – Exo Therapeutics, Inc.
Broad, HHMI Founder: Editas, Beam, Prime, Chroma. Richard Merkin Professor and Director Merkin Institute Core Institute Member Vice-Chair Faculty, Broad Institute Investigator, Howard …See details»
Our Story – Exo Therapeutics, Inc.
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightâ„¢ platform, we are developing a deep …See details»
Exo Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Exo Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Exo Therapeutics - Funding, Financials, Valuation & Investors
Exo Therapeutics is a small molecule drug discovery and development company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Exo Therapeutics - LinkedIn
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM ...See details»
Exo Therapeutics - PitchBook
Exo Therapeutics General Information Description. Developer of a drug discovery technology designed to address intractable pharmaceutical targets. The company's technology develops a …See details»
Exo Therapeutics - Contacts, Employees, Board Members
Organization. Exo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of …See details»
Exo Therapeutics - VentureRadar
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to addressintractable pharmaceutical targets. By leveraging the company’s …See details»
Exo Therapeutics | C&EN Global Enterprise - ACS …
Nov 7, 2022 The team quickly realized that inhibiting exosites had enormous potential for solving some problems in drug discovery. This realization set the three scientists on the path to launching Exo Therapeutics, which announced …See details»
Exo Therapeutics raises $78 million to target enzyme exosites with ...
Oct 5, 2021 The work, which was led by Liu’s then-PhD student Juan Pablo Maianti, formed the basis of Exo, which was founded in 2018 with Alan Saghatelian at the Salk Institute for …See details»
Novartis-backed Exo Therapeutics secures $78M to reprogram …
Oct 5, 2021 Exo Therapeutics snagged $78 million in series B funds to get closer to its vision of reprogramming enzymes without toxic side effects and the ability to precisely hit the desired …See details»
Exo Therapeutics snags $25M to handle 'undruggable' enzymes …
Dec 16, 2020 In the next year, the new financing, drawn from Newpath Partners, Novartis Venture Fund, CRV and 6 Dimensions Capital, will enable Exo Therapeutics to identify more …See details»
Exo Announces Lead Program, Targeting TANK Binding Kinase 1 …
May 23, 2023 About Exo Therapeutics Exo Therapeutics is a small molecule drug discovery and development company co-founded by Professors David R. Liu, Alan Saghatelian, and Juan …See details»
Exo Therapeutics adds $78M as cancer, inflammation drugs march …
Oct 5, 2021 Biotech startup Exo Therapeutics is developing a way to drug proteins by targeting places distant from a traditional binding site, and by doing so, affecting enzymes to produce a …See details»
Exo Therapeutics Launches with $25 Million Series A Financing to …
Dec 16, 2020 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exo Therapeutics, Inc., a small molecule drug discovery and development company with a pioneering technology to address …See details»
Exo Therapeutics Raises $78 Million Series B Financing
Oct 5, 2021 Exo Therapeutics announces the completion of a $78 million Series B financing Contacts Company Contact : Sarah Keane [email protected] Media …See details»
Pipeline – Exo Therapeutics, Inc.
Our ExoSightâ„¢ platform can be applied across enzyme classes to discover innovative therapeutic candidates across many diseases. Our proprietary programs are initially focused in oncology …See details»
ExoXpert, a CDMO launched by EXO Biologics to service increasing ...
Liege, Belgium, January 31, 2024 – EXO Biologics SA, a Belgian biotech company committed to developing biopharmaceuticals using exosomes to treat rare diseases with high unmet …See details»